Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Miller

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of Addiction Medicine|February 15, 2022
Linking Emergency Services to Chronic Disease Management for AddictionMichael M Miller
JAMA|February 24, 2006
Heroin detoxificationMichael M Miller
WMJ : Official Publication of the State Medical Society of Wisconsin|October 13, 2005
Kudos for tobacco issueMichael M Miller
Journal of Addiction Medicine|July 20, 2011
Medication groups for office based opioid treatmentMichael M Miller
Journal of Addiction Medicine|January 24, 2020
Decisions to Use Lofexidine or ClonidineMichael M Miller
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2014
Re: sympathomimetic drugs should be considered an alternative agent class in refractory chronic urticariaMichael M Miller
Journal of Psychoactive Drugs|August 14, 2012
The medicalization of addiction treatment professionalsA Kenison Roy, Michael M Miller
American Family Physician|March 30, 2007
Prescription drug monitoring programsMichael M Miller, Randall T Brown
The Journal of Allergy and Clinical Immunology|October 8, 2005
Beta-blockers and anaphylaxis: are the risks overstated?Michael M Miller, Martin M Miller
Patient Preference and Adherence|April 15, 2014
Impact of patient satisfaction ratings on physicians and clinical careAleksandra Zgierska, David Rabago, Michael M Miller
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of Addiction Medicine|February 15, 2022
Linking Emergency Services to Chronic Disease Management for AddictionMichael M Miller
JAMA|February 24, 2006
Heroin detoxificationMichael M Miller
WMJ : Official Publication of the State Medical Society of Wisconsin|October 13, 2005
Kudos for tobacco issueMichael M Miller
Journal of Addiction Medicine|July 20, 2011
Medication groups for office based opioid treatmentMichael M Miller
Journal of Addiction Medicine|January 24, 2020
Decisions to Use Lofexidine or ClonidineMichael M Miller
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2014
Re: sympathomimetic drugs should be considered an alternative agent class in refractory chronic urticariaMichael M Miller
Journal of Psychoactive Drugs|August 14, 2012
The medicalization of addiction treatment professionalsA Kenison Roy, Michael M Miller
American Family Physician|March 30, 2007
Prescription drug monitoring programsMichael M Miller, Randall T Brown
The Journal of Allergy and Clinical Immunology|October 8, 2005
Beta-blockers and anaphylaxis: are the risks overstated?Michael M Miller, Martin M Miller
Patient Preference and Adherence|April 15, 2014
Impact of patient satisfaction ratings on physicians and clinical careAleksandra Zgierska, David Rabago, Michael M Miller
Pageof 4